A patient with HIV and tuberculosis with diminished clopidogrel response

International Journal of STD and AIDS

Volumn 25, Issue 7, 2014, Pages 532-534

  Metzger, Nicole L ^a   Momary, Kathryn M ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

AIDS; Antibiotic; antiviral; clopidogrel; drug drug interactions; highly active antiretroviral therapy; HIV; isoniazid ritonavir

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; CLOPIDOGREL; ISONIAZID; RITONAVIR; ANTITHROMBOCYTIC AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; TICLOPIDINE; TUBERCULOSTATIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; ELECTROCARDIOGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PNEUMONIA; PRIORITY JOURNAL; SINUS RHYTHM; T WAVE INVERSION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; TREATMENT RESPONSE; TUBERCULOSIS; VIRUS PNEUMONIA; ANALOGS AND DERIVATIVES; COMPLICATION; DRUG INTERACTION; DRUG RESISTANCE; HIV INFECTIONS; MYOCARDIAL INFARCTION;

ANTITUBERCULAR AGENTS; DRUG INTERACTIONS; DRUG RESISTANCE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; ISONIAZID; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RITONAVIR; TICLOPIDINE; TUBERCULOSIS;

EID: 84900403669     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413516099     Document Type: Article

References (7)

1. Roden DM,Stein CM.Clopidogrel and the concept of high-risk pharmacokinetics.Circulation. 2009;119:2127-2130.
2. Momary KM,Dorsch MP.Factors associated with clopidogrel nonresponsiveness.Future Cardiol. 2010;6:195-210.
3. Moerenhout CM,Claeys MJ,Haine S,et al.Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.Am Heart J. 2010;159:434-438.
4. Wright RS,Anderson JL,Adams CD,et al.2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.J Am Coll Cardiol. 2011;57:1920-1959.
5. Reny JL,De Moerloose P,Dauzat M,et al.Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.J Thromb Haemost. 2008;6:444-450.
6. Deck DH, Winston LG and Winston LF. Antimycobacterial drugs. In: Katzung BG, Masters SB and Trevor AJ (eds) Basic & Clinical Pharmacology. 12th ed. New York: McGraw-Hill, 2012. http://www.accesspharmacy.com/content.aspx?aID=55829715 (2012, accessed 9 August 2013).
7. Desta Z,Soukhova NV,Flockhart DA.Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.Antimicrob Agents Chemother. 2001;45:382-392.